WASHINGTON (AP) — Federal health regulators are weighing the risks of permitting Merck to sell its prescription respiratory pill, Singulair, as an over-the-counter medicine for allergies.
via Health News Headlines - Yahoo News http://ift.tt/1n1Deme
via Health News Headlines - Yahoo News http://ift.tt/1n1Deme
No comments:
Post a Comment